Package 70069-788-04

{"route": ["INTRAVENOUS"], "spl_id": "d34802e0-7b94-49bd-b056-e28ad18e7418", "openfda": {"nui": ["N0000175429", "N0000175961", "N0000008867", "N0000175960", "N0000175776", "N0000175547"], "upc": ["0370069788011", "0370069788042"], "unii": ["WYQ7N0BPYC"], "rxcui": ["465377"], "spl_set_id": ["b8d3ed96-d7ee-43f4-986c-a7d04808711a"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]"], "pharm_class_epc": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Mucolytic [EPC]"], "pharm_class_moa": ["Reduction Activity [MoA]"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL in 1 CARTON (70069-788-04)  / 30 mL in 1 VIAL", "package_ndc": "70069-788-04", "marketing_start_date": "20240613"}], "brand_name": "Acetylcysteine", "product_id": "70069-788_d34802e0-7b94-49bd-b056-e28ad18e7418", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]", "Mucolytic [EPC]", "Reduction Activity [MoA]"], "product_ndc": "70069-788", "generic_name": "Acetylcysteine", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetylcysteine", "active_ingredients": [{"name": "ACETYLCYSTEINE", "strength": "200 mg/mL"}], "application_number": "ANDA218397", "marketing_category": "ANDA", "marketing_start_date": "20240613", "listing_expiration_date": "20261231"}